Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...

Massachusetts' largest commercial health insurer is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Explore the benefits of Mochi Health, a telehealth platform offering personalized weight loss solutions and support.

The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co., a Chinese pharmaceutical company. Novo Nordisk will pay $200 ... of advanced weight-loss treatments.

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

Trump’s Health and Human Services secretary, Robert F. Kennedy Jr., has been an outspoken opponent of the injectable drugs, which have exploded in popularity due to the potentially life-changing ...

highlights that weight loss programmes often fail to meet their set targets and overlook other important factors like improving obesity-related health issues, quality of life, and physical and ...

Medicare covers health care expenses mainly for people ... FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1 ...

Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health complications.